Financials
Financial year 2025
WANDJI PHARMA INTERNATIONAL from Tournai, company number BE0555655986, closed financial year 2025 with a result of € -44,567 after tax. For that financial year WANDJI PHARMA INTERNATIONAL recorded a gross margin of € -34,577 and equity of € 45,275. Compared with financial year 2024, the result moved from € 22,455 to € -44,567. The company made a loss. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on November 10, 2026.
€ 45,275
▼ 50% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -44,567
▼ still € 22,455 profit in 2024
Profit after tax over the fiscal year.
€ 138,523
▼ 27% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -98,325.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
Debts at end 2025
€ 188,876
▼ 5% vs 2024
€ 28,998 is repaid this year. At this pace the long-term loan is gone in ≈ 7 years.
€ 17,475
▲ 64% vs 2024
Supplier invoices still open on the last day of the fiscal year.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € -913 | € 38,915 | € 30,451 | € -34,577 | ▼ € 65,028 |
| Profit after taxes | € -4,548 | € 19,533 | € 22,455 | € -44,567 | ▼ € 67,021 |
| Equity | € -77,147 | € 67,387 | € 89,841 | € 45,275 | ▼ 50% |
| Total debts | € 213,098 | € 97,955 | € 267,276 | € 270,037 | ▲ 1% |
| Cash | € 30 | € 597 | € 190,510 | € 138,523 | ▼ 27% |
| Retained profit | € -95,747 | € -76,213 | € -53,759 | € -98,325 | ▼ € 44,567 |
| Bank debt | € 36,871 | € 23,414 | € 199,339 | € 188,876 | ▼ 5% |
| Balance sheet total | € 135,951 | € 165,342 | € 357,118 | € 315,311 | ▼ 12% |
By gross margin, WANDJI PHARMA INTERNATIONAL ranks 4th of 4 companies with main activity “Vervaardiging van geneesmiddelen” in Hainaut that publish figures (fiscal year 2025).
Key figures of WANDJI PHARMA INTERNATIONAL, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about WANDJI PHARMA INTERNATIONAL the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to WANDJI PHARMA INTERNATIONAL?
What happened at WANDJI PHARMA INTERNATIONAL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 44,567 (▼ € 67,021 vs 2024). filed late Source: NBB ↗
- FABRICE WANDJI became a director. NBB
- Incorporation, published in the Gazette. Source: Staatsblad ↗
- New establishment in Tournai. KBO
In short
From € 4,548 loss in 2022 to € 44,567 loss in 2025.
Paid € 3 in corporate taxes since 2022.
Best year ever: 2024, with € 22,455 profit.
Management
The stake of REANESURG WANDJI comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
WANDJI PHARMA INTERNATIONALBehind WANDJI PHARMA INTERNATIONAL is FABRICE WANDJI. The shares are held by REANESURG WANDJI (87%).
Directors
According to the 2025 annual accounts
FABRICE WANDJI
Director
since 2024
Shareholders
87%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Chaussée de Frasnes(MEL) 502
7540 Tournai
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Hainaut
Same main activity (Vervaardiging van geneesmiddelen), 10 active companies in Hainaut, largest first.
€ 374.2 million revenue · 2026 · Lessines
€ 106.6 million revenue · 2025 · Lessines
€ 17 million revenue · 2025 · Courcelles
€ 10 million revenue · 2023 · Charleroi
€ 4.2 million gross margin · 2025 · Charleroi
€ 3.7 million revenue · 2025 · Mouscron
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- WANDJI TCHAMI fabrice(oprichter) 100%
Details
- Company number
- 0555.655.986
- VAT number
- BE 0555.655.986
- Registered office
- Chaussée de Frasnes(MEL) 502, 7540 Tournai
- Names & denominations
- WANDJI PHARMA INTERNATIONAL
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 3 July 2014
- Peppol
- Active · Active since 27 Nov 2025
- Activities · NACE
Vervaardiging van geneesmiddelen
Detailhandel in farmaceutische producten